<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">emcardio</journal-id><journal-title-group><journal-title xml:lang="ru">Неотложная кардиология и кардиоваскулярные риски</journal-title><trans-title-group xml:lang="en"><trans-title>Emergency Cardiology and Cardiovascular Risks journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2616-633X</issn><publisher><publisher-name>Белорусский государственный медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.51922/2616-633X.2025.9.2.2633</article-id><article-id custom-type="elpub" pub-id-type="custom">emcardio-324</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные научные публикации</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original Scientific Research</subject></subj-group></article-categories><title-group><article-title>Показатели продольной деформации левого предсердия у пациентов с гипертонической болезнью и псориазом</article-title><trans-title-group xml:lang="en"><trans-title>Indicators of longitudinal deformation of the left atrium in patients with hypertension and psoriasis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Субботин</surname><given-names>А. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Subbotin</surname><given-names>A. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра внутренних болезней, ФГАОУ ВО «Национальный исследовательский Нижегородский государственный университет им. Н.И. Лобачевского»</p><p>Нижний Новгород</p></bio><bio xml:lang="en"><p>Department of Internal Medicine, National Research State University of Nizhny Novgorod</p><p>Nizhny Novgorod</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Григорьева</surname><given-names>Н. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Grigorieva</surname><given-names>N. U.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра внутренних болезней</p><p>Нижний Новгород</p></bio><bio xml:lang="en"><p>Department of Internal Medicine</p><p>Nizhny Novgorod</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мазалов</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mazalov</surname><given-names>K. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра внутренних болезней, ФГАОУ ВО «Национальный исследовательский Нижегородский государственный университет им. Н.И. Лобачевского»</p><p>Нижний Новгород</p></bio><bio xml:lang="en"><p>Department of Internal Medicine, National Research State University of Nizhny Novgorod</p><p>Nizhny Novgorod</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богданович</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogdanovich</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нижний Новгород</p></bio><bio xml:lang="en"><p>Nizhny Novgorod</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Яшина</surname><given-names>Е. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Yashina</surname><given-names>E. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра внутренних болезней</p><p>Нижний Новгород</p></bio><bio xml:lang="en"><p>Department of Internal Medicine</p><p>Nizhny Novgorod</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каримов</surname><given-names>Р. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Karimov</surname><given-names>R. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра внутренних болезней</p><p>Нижний Новгород</p></bio><bio xml:lang="en"><p>Department of Internal Medicine</p><p>Nizhny Novgorod</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Национальный исследовательский Нижегородский государственный университет им. Н.И. Лобачевского»;&#13;
ФБУЗ Приволжский окружной медицинский центр ФМБА России</institution></aff><aff xml:lang="en"><institution>National Research State University of Nizhny Novgorod;&#13;
Volga Medical Centre</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО «Национальный исследовательский Нижегородский государственный университет им. Н.И. Лобачевского»</institution></aff><aff xml:lang="en"><institution>National Research State University of Nizhny Novgorod</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФБУЗ Приволжский окружной медицинский центр ФМБА России</institution></aff><aff xml:lang="en"><institution>Volga Medical Centre</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>25</day><month>01</month><year>2026</year></pub-date><volume>9</volume><issue>2</issue><fpage>2633</fpage><lpage>2641</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Субботин А.К., Григорьева Н.Ю., Мазалов К.В., Богданович О.В., Яшина Е.М., Каримов Р.Р., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Субботин А.К., Григорьева Н.Ю., Мазалов К.В., Богданович О.В., Яшина Е.М., Каримов Р.Р.</copyright-holder><copyright-holder xml:lang="en">Subbotin A.K., Grigorieva N.U., Mazalov K.V., Bogdanovich O.V., Yashina E.M., Karimov R.R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://emcardio.bsmu.by/jour/article/view/324">https://emcardio.bsmu.by/jour/article/view/324</self-uri><abstract><p>Цель исследования – оценка выраженности ремоделирования левого предсердия методом определения глобальной продольной деформации миокарда у пациентов с гипертонической болезнью (ГБ) и сопутствующим псориазом с последующей оценкой влияния на частоту выявления нарушений ритма сердца.</p><sec><title>Материалы и методы</title><p>Материалы и методы. Проведено когортное проспективное исследование с включением пациентов с ГБ и псориазом в сравнении с группой пациентов с ГБ без псориаза. Пациентам проводилось клинико-диагностическое обследование с акцентом на суточное мониторирование ЭКГ, эхокардиографическое исследование с определением продольной деформации левого желудочка и левого предсердия. В ходе исследования было выполнено обследование 96 пациентов с ГБ. Пациенты были распределены на две группы: основная группа – группа 1 (n = 60) – пациенты с ГБ и псориазом, контрольная группа – группа 2 (n = 36) – пациенты с ГБ без сопутствующего псориаза.</p></sec><sec><title>Результаты</title><p>Результаты. Пациенты обоих групп имели статистически равномерное распределение по возрасту, полу и антропометрическим характеристикам, гемодинамическим параметрам на момент включения в исследование. В группе пациентов с псориазом достоверно чаще возникала частая суправентрикулярная экстрасистолия и пароксизмы неустойчивой суправентрикулярной тахикардии: 43,13 % в 1 группе и 26,21 % в 2 группе (р = 0,031). Также у пациентов с ГБ и сопутствующим псориазом достоверно чаще встречалось снижение деформации миокарда левого предсердия в фазу резервуара (LASr = 23,12 ± 5,64 в группе 1 и 28,31 ± 6,36 в группе 2 (р = 0,004)), при сопоставимых значениях деформации в фазу протекания и сокращения. Кроме того, в группе 1 отмечалась большая выраженность нарушения диастолической функции левого желудочка по данным тканевой допплерографии (Е/е’ = 11,42+/-2,47 в группе 1 и 9,21+/–2,22 в группе 2 (р = 0,0065)).</p></sec><sec><title>Заключение</title><p>Заключение. По нашим данным, пациенты с ГБ и сопутствующим псориазом, по сравнению с пациентами ГБ без псориаза, достоверно чаще имели нарушение деформации левого предсердия в фазе резервуара, а также более выраженную диастолическую дисфункцию левого желудочка, оцениваемую по данным тканевой допплерографии, что сочеталось с более частыми пароксизмами неустойчивой суправентрикулярной тахикардии.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>The aim of the study</title><p>The aim of the study. To evaluate the severity of left atrial remodeling by measuring global longitudinal myocardial strain in patients with hypertension and concomitant psoriasis followed by the assessment of the effect on the frequency of cardiac arrhythmias.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. A prospective cohort study was conducted including the patients with hypertension and psoriasis compared with a group of patients with hypertension without psoriasis. The patients underwent a clinical diagnostic examination with an emphasis on daily ECG monitoring, echocardiographic examination to determine the longitudinal deformation of the left ventricle and left atrium. 96 patients with hypertension were examined in the course of the study. The patients were divided into two groups: the main group group 1 (n = 60 patients) – patients with hypertension and psoriasis, the control group – group 2 (n = 36 patients) – patients with hypertension without concomitant psoriasis.</p></sec><sec><title>Results</title><p>Results. The patients of both groups had a statistically equal distribution by age, gender, and anthropometric characteristics, hemodynamic parameters at the time of inclusion in the study, the duration of hypertension, and the structure of concomitant pathology. In the group of patients with psoriasis, frequent supraventricular extrasystole and paroxysms of unstable supraventricular tachycardia were significantly more common: 43.13 % in group 1 and 26.21 % in group 2 (p = 0.031). Besides, in patients with hypertension and concomitant psoriasis, a decrease in left atrial myocardial strain in the reservoir phase was more frequent (LASr = 23.12 ± 5.64 in the group of patients with psoriasis and 28.31 ± 6.36 in the control group (p = 0.004)), with comparable strain readings in the flow and contraction phases. In addition, in Group 1, there was a greater severity of left ventricular diastolic dysfunction according to tissue dopplerography (E/e’ = 11.42+/–2.47 in Group 1 and 9.21+/–2.22 in Group 2 (p = 0.0065)).</p></sec><sec><title>Conclusion</title><p>Conclusion. According to our data, patients with hypertension and concomitant psoriasis were significantly more likely to have left atrial strain in the reservoir phase, as well as more pronounced diastolic dysfunction of the left ventricle, assessed by tissue dopplerography, which was combined with more frequent paroxysms of unstable supraventricular tachycardia.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>гипертоническая болезнь</kwd><kwd>псориаз</kwd><kwd>продольная деформация левого предсердия</kwd><kwd>нарушения ритма сердца</kwd><kwd>диастолическая дисфункция</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hypertension</kwd><kwd>psoriasis</kwd><kwd>left atrial longitudinal strain</kwd><kwd>cardiac arrhythmias</kwd><kwd>diastolic dysfunction</kwd><kwd>heart failure with preserved ejection fraction</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kobalava Zh.D., Konradi A.O., Nedogoda S.V. et al. Clinical practice guidelines for Hypertension in adults. Russian Journal of Cardiology. 2024, vol. 29(9), pp. 6117, https://doi.org/10.15829/1560-4071-2024-6117. (in Russian).</mixed-citation><mixed-citation xml:lang="en">Kobalava Zh.D., Konradi A.O., Nedogoda S.V. et al. Clinical practice guidelines for Hypertension in adults. Russian Journal of Cardiology. 2024, vol. 29(9), pp. 6117, https://doi.org/10.15829/1560-4071-2024-6117. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Masson W., Lobo M., Molinero G. Psoriasis and cardiovascular risk: a comprehensive review. Advances in Therapy. 2020, vol. 37(5), pp. 2017–2033. https://doi:10.1007/s12325-020-01346-6.</mixed-citation><mixed-citation xml:lang="en">Masson W., Lobo M., Molinero G. Psoriasis and cardiovascular risk: a comprehensive review. Advances in Therapy. 2020, vol. 37(5), pp. 2017–2033. https://doi:10.1007/s12325-020-01346-6.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Psoriasis. Clinical guidelines 2023: Approved at the meeting of the Scientific and Practical Council of the Ministry of Health of the Russian Federation (minutes No. 23) on December 27, 2022. (in Russian).</mixed-citation><mixed-citation xml:lang="en">Psoriasis. Clinical guidelines 2023: Approved at the meeting of the Scientific and Practical Council of the Ministry of Health of the Russian Federation (minutes No. 23) on December 27, 2022. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Garshick M.S., Ward N.L., Krueger J.G., Berger J.S. Cardiovascular risk in patients with psoriasis. Journal of the American College of Cardiology. 2021, vol. 77(13), pp. 1670– 1680, https://doi:10.1016/j.jacc.2021.02.009.</mixed-citation><mixed-citation xml:lang="en">Garshick M.S., Ward N.L., Krueger J.G., Berger J.S. Cardiovascular risk in patients with psoriasis. Journal of the American College of Cardiology. 2021, vol. 77(13), pp. 1670– 1680, https://doi:10.1016/j.jacc.2021.02.009.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Salihbegovic E.M., Hadzigrahic N., Suljagic E. et al. Psoriasis and high blood pressure. Med Arch, 2015, vol. 69(1), pp. 13–15, ht tps://doi:10.5455/medarh.2015.69.13-15.</mixed-citation><mixed-citation xml:lang="en">Salihbegovic E.M., Hadzigrahic N., Suljagic E. et al. Psoriasis and high blood pressure. Med Arch, 2015, vol. 69(1), pp. 13–15, ht tps://doi:10.5455/medarh.2015.69.13-15.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Takeshita J., Wang S., Shin D.B. et al. Effect of psoriasis severity on hypertension control. JAMA Dermatology. 2015, vol. 151(2), pp. 161–169. https://doi:10.1001/jamadermatol.2014.2094.</mixed-citation><mixed-citation xml:lang="en">Takeshita J., Wang S., Shin D.B. et al. Effect of psoriasis severity on hypertension control. JAMA Dermatology. 2015, vol. 151(2), pp. 161–169. https://doi:10.1001/jamadermatol.2014.2094.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Gelfand J.M., Dommasch E.D., Shin D.B. et al. The risk of stroke in patients with psoriasis. Journal of Investigative Dermatology. 2009, vol. 129(10), pp. 2411–2418. https://doi:10.1038/jid.2009.112.</mixed-citation><mixed-citation xml:lang="en">Gelfand J.M., Dommasch E.D., Shin D.B. et al. The risk of stroke in patients with psoriasis. Journal of Investigative Dermatology. 2009, vol. 129(10), pp. 2411–2418. https://doi:10.1038/jid.2009.112.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Packer M. Potential role of atrial myopathy in the pathogenesis of stroke in rheumatoid arthritis and psoriasis: a conceptual framework and implications for prophylaxis. Journal of the American Heart Association. 2020, vol. 9(3), e014764. https://doi:10.1161/jaha.119.014764.</mixed-citation><mixed-citation xml:lang="en">Packer M. Potential role of atrial myopathy in the pathogenesis of stroke in rheumatoid arthritis and psoriasis: a conceptual framework and implications for prophylaxis. Journal of the American Heart Association. 2020, vol. 9(3), e014764. https://doi:10.1161/jaha.119.014764.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Aune D., Mahamat-Saleh Y., Kobeissi E. et al. Blood pressure, hypertension and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2023, vol. 38, pp. 145–178, https://doi.org/10.1007/s10654-022-00914-0.</mixed-citation><mixed-citation xml:lang="en">Aune D., Mahamat-Saleh Y., Kobeissi E. et al. Blood pressure, hypertension and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2023, vol. 38, pp. 145–178, https://doi.org/10.1007/s10654-022-00914-0.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ikejder Y., Sebbani M., Hendy I. et al. Impact of arterial hypertension on left atrial size and function. BioMed Research International. 2020, Sep 14., pp. 1–7. https://doi:10.1155/2020/2587530.</mixed-citation><mixed-citation xml:lang="en">Ikejder Y., Sebbani M., Hendy I. et al. Impact of arterial hypertension on left atrial size and function. BioMed Research International. 2020, Sep 14., pp. 1–7. https://doi:10.1155/2020/2587530.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Cameli M., Mandoli G.E., Loiacono F. et al. Left atrial strain: a useful index in atrial fibrillation. International Journal of Cardiology. 2016, vol. 220, pp. 208–213. https://doi:10.1016/j.ijcard.2016.06.197.</mixed-citation><mixed-citation xml:lang="en">Cameli M., Mandoli G.E., Loiacono F. et al. Left atrial strain: a useful index in atrial fibrillation. International Journal of Cardiology. 2016, vol. 220, pp. 208–213. https://doi:10.1016/j.ijcard.2016.06.197.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Cameli M., Lisi M., Righini F.M. et al. Left atrial strain in patients with arterial hypertension. International Cardiovascular Forum Journal. 2015. https://doi:10.17987/icfj.v1i1.12.</mixed-citation><mixed-citation xml:lang="en">Cameli M., Lisi M., Righini F.M. et al. Left atrial strain in patients with arterial hypertension. International Cardiovascular Forum Journal. 2015. https://doi:10.17987/icfj.v1i1.12.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor W., Gladman D., Helliwell P. et al. ; CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006, vol. 54(8), pp. 2665–2673. https://doi:10.1002/art.21972.</mixed-citation><mixed-citation xml:lang="en">Taylor W., Gladman D., Helliwell P. et al. ; CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006, vol. 54(8), pp. 2665–2673. https://doi:10.1002/art.21972.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Verdecchia P., Angeli F., Reboldi G. Hypertension and atrial fibrillation. Circulation Research. 2018, vol. 122(2), pp. 352–368. ht tps://doi:10.1161/circresaha.117.311402.</mixed-citation><mixed-citation xml:lang="en">Verdecchia P., Angeli F., Reboldi G. Hypertension and atrial fibrillation. Circulation Research. 2018, vol. 122(2), pp. 352–368. ht tps://doi:10.1161/circresaha.117.311402.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Patrick D.M., Van Beusecum J.P., Kirabo A. The role of inflammation in hypertension: novel concepts. Current Opinion in Physiology. 2021, vol. 19, pp. 92–98. https://doi:10.1016/j.cophys.2020.09.016.</mixed-citation><mixed-citation xml:lang="en">Patrick D.M., Van Beusecum J.P., Kirabo A. The role of inflammation in hypertension: novel concepts. Current Opinion in Physiology. 2021, vol. 19, pp. 92–98. https://doi:10.1016/j.cophys.2020.09.016.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">De Jong S., Van Veen T.A., Van Rijen H.V., De Bakker J.M. Fibrosis and cardiac arrhythmias. Journal of Cardiovascular Pharmacology. 2021, vol. 57(6), pp. 630–638. https://doi:10.1097/fjc.0b013e318207a35f.</mixed-citation><mixed-citation xml:lang="en">De Jong S., Van Veen T.A., Van Rijen H.V., De Bakker J.M. Fibrosis and cardiac arrhythmias. Journal of Cardiovascular Pharmacology. 2021, vol. 57(6), pp. 630–638. https://doi:10.1097/fjc.0b013e318207a35f.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ischemic stroke and transient ischemic attack. Clinical guidelines 2024. – Moscow, 2024. 328 p. (in Russian).</mixed-citation><mixed-citation xml:lang="en">Ischemic stroke and transient ischemic attack. Clinical guidelines 2024. – Moscow, 2024. 328 p. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kadappu K.K., Thomas L. Tissue doppler imaging in echocardiography: value and limitations. Heart Lung and Circulation. 2015, vol. 24(3), pp. 224–233. https://doi:10.1016/j.hlc.2014.10.003.</mixed-citation><mixed-citation xml:lang="en">Kadappu K.K., Thomas L. Tissue doppler imaging in echocardiography: value and limitations. Heart Lung and Circulation. 2015, vol. 24(3), pp. 224–233. https://doi:10.1016/j.hlc.2014.10.003.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Alekhine M.N. Two-dimensional speckle tracking echocardiography for assessing myocardial and cardiac chamber deformation. VIDAR, 2022, pp. 51–65. (in Russian).</mixed-citation><mixed-citation xml:lang="en">Alekhine M.N. Two-dimensional speckle tracking echocardiography for assessing myocardial and cardiac chamber deformation. VIDAR, 2022, pp. 51–65. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ovchinnikov A.G., Potekhina A.V., Filatova A.Yu. et al. The role of the left atrium in the pathogenesis of heart failure with preserved ejection fraction. Kardiologiia. 2024, vol. 64(11), pp. 132–147. https://doi.org/10.18087/cardio.2024.11.n2799. (in Russian).</mixed-citation><mixed-citation xml:lang="en">Ovchinnikov A.G., Potekhina A.V., Filatova A.Yu. et al. The role of the left atrium in the pathogenesis of heart failure with preserved ejection fraction. Kardiologiia. 2024, vol. 64(11), pp. 132–147. https://doi.org/10.18087/cardio.2024.11.n2799. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Obokata M., Reddy Y.N.V., Borlaug B.A. Diastolic dysfunction and heart failure with preserved ejection fraction: understanding mechanisms by using noninvasive methods. JACC: Cardiovascular Imaging. 2020, vol. 13(1), pp. 245–57. https://doi.org/10.1016/j.jcmg.2018.12.034.</mixed-citation><mixed-citation xml:lang="en">Obokata M., Reddy Y.N.V., Borlaug B.A. Diastolic dysfunction and heart failure with preserved ejection fraction: understanding mechanisms by using noninvasive methods. JACC: Cardiovascular Imaging. 2020, vol. 13(1), pp. 245–57. https://doi.org/10.1016/j.jcmg.2018.12.034.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
